Clinical significance of elevated spleen tyrosine kinase expression in nasopharyngeal carcinoma

Head and Neck

Volumn 34, Issue 10, 2012, Pages 1456-1464

  Du, Zi Ming ^a,b   Kou, Chang Wei ^a   Wang, Hai Yun ^a   Huang, Ma Yan ^a   Liao, Ding Zhun ^a   Hu, Chun Fang ^c   Chen, Jing ^a   Yan, Li Xu ^a   Hu, Li Fu ^b   Ernberg, Ingemar ^b   Zeng, Yi Xin ^a   Shao, Jian Yong ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

LMP2A (Epstein Barr virus encoded latent membrane protein 2A); NPC (nasopharyngeal carcinoma); poor prognosis; recurrence; Syk (spleen tyrosine kinase)

Indexed keywords

LATENT MEMBRANE PROTEIN 2; LATENT MEMBRANE PROTEIN 2A; PROTEIN KINASE SYK; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENZYME SUBSTRATE COMPLEX; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADULT; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; BLOTTING, WESTERN; COHORT STUDIES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEIN-TYROSINE KINASES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TISSUE EMBEDDING; VIRAL MATRIX PROTEINS;

EID: 84866373771     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21953     Document Type: Article

References (30)

1. Licitra L, Bernier J, Cvitkovic E, et al. Cancer of the nasopharynx. Crit Rev Oncol Hematol 2003; 45: 199-213.
2. Titcomb CP Jr,. High incidence of nasopharyngeal carcinoma in Asia. J Insur Med 2001; 33: 235-238.
3. Kumar S, Mahanta J,. Aetiology of nasopharyngeal carcinoma. A review. Indian J Cancer 1998; 35: 47-56.
4. Shao JY, Li YH, Gao HY, et al. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Cancer 2004; 100: 1162-1170.
5. Hong MH, Mai HQ, Min HQ, Ma J, Zhang EP, Cui NJ,. A comparison of the Chinese 1992 and fifth-edition International Union Against Cancer staging systems for staging nasopharyngeal carcinoma. Cancer 2000; 89: 242-247. (Pubitemid 30489869)
6. Heng DM, Wee J, Fong KW, et al. Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma. Cancer 1999; 86: 1912-1920.
7. Sada K, Takano T, Yanagi S, Yamamura H,. Structure and function of Syk protein-tyrosine kinase. J Biochem 2001; 130: 177-186. (Pubitemid 32785863)
8. Fruehling S, Swart R, Dolwick KM, Kremmer E, Longnecker R,. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency. J Virol 1998; 72: 7796-7806. (Pubitemid 28421769)
9. Lu J, Lin WH, Chen SY, et al. Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells. J Biol Chem 2006; 281: 8806-8814. (Pubitemid 43847987)
10. Toyama T, Iwase H, Yamashita H, et al. Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer. Cancer Lett 2003; 189: 97-102. (Pubitemid 35351524)
11. Layton T, Stalens C, Gunderson F, Goodison S, Silletti S,. Syk tyrosine kinase acts as a pancreatic adenocarcinoma tumor suppressor by regulating cellular growth and invasion. Am J Pathol 2009; 175: 2625-2636.
12. Yuan Y, Wang J, Li J, et al. Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma. Clin Cancer Res 2006; 12: 6687-6695. (Pubitemid 44876836)
13. Kunze E, Wendt M, Schlott T,. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas. Int J Mol Med 2006; 18: 547-557.
14. Nakashima H, Natsugoe S, Ishigami S, et al. Clinical significance of nuclear expression of spleen tyrosine kinase (Syk) in gastric cancer. Cancer Lett 2006; 236: 89-94.
15. Luangdilok S, Box C, Patterson L, et al. Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck. Cancer Res 2007; 67: 7907-7916. (Pubitemid 47281387)
16. Feldman AL, Sun DX, Law ME, et al. Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas. Leukemia 2008; 22: 1139-1143. (Pubitemid 351833780)
17. Wilcox RA, Sun DX, Novak A, Dogan A, Ansell SM, Feldman AL,. Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin's lymphoma cell lines. Leukemia 2010; 24: 229-232.
18. Baudot AD, Jeandel PY, Mouska X, et al. The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression. Oncogene 2009; 28: 3261-3273.
19. Uckun FM, Ozer Z, Qazi S, Tuel-Ahlgren L, Mao C,. Polo-like- kinase 1 (PLK1) as a molecular target to overcome SYK-mediated resistance of B-lineage acute lymphoblastic leukaemia cells to oxidative stress. Br J Haematol 2010; 148: 714-725.
20. Min H, Hong M, Ma J, et al. A new staging system for nasopharyngeal carcinoma in China. Int J Radiat Oncol Biol Phys 1994; 30: 1037-1042.
21. Li YH, Hu CF, Shao Q, et al. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma. J Transl Med 2008; 6: 1.
22. Du ZM, Hu CF, Shao Q, et al. Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients. Int J Cancer 2009; 125: 1832-1841.
23. Kong QL, Hu LJ, Cao JY, et al. Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma. PLoS Pathog 2010; 6: e1000940.
24. Lu J, Chen SY, Chua HH, et al. Upregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator Zta. J Virol 2000; 74: 7391-7399. (Pubitemid 30613084)
25. Szeles A, Falk KI, Imreh S, Klein G,. Visualization of alternative Epstein-Barr virus expression programs by fluorescent in situ hybridization at the cell level. J Virol 1999; 73: 5064-5069. (Pubitemid 29246768)
26. Futterer K, Wong J, Grucza RA, Chan AC, Waksman G,. Structural basis for Syk tyrosine kinase ubiquity in signal transduction pathways revealed by the crystal structure of its regulatory SH2 domains bound to a dually phosphorylated ITAM peptide. J Mol Biol 1998; 281: 523-537. (Pubitemid 28372129)
27. Brooks L, Yao QY, Rickinson AB, Young LS,. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 1992; 66: 2689-2697.
28. Merchant M, Caldwell RG, Longnecker R,. The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo. J Virol 2000; 74): 9115-9124.
29. Ikeda M, Longnecker R,. The c-Cbl proto-oncoprotein downregulates EBV LMP2A signaling. Virology 2009; 385: 183-191.
30. Pegtel DM, Subramanian A, Sheen TS, Tsai CH, Golub TR, Thorley-Lawson DA,. Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis. J Virol 2005; 79: 15430-15442. (Pubitemid 43032325)